Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Merck & Co
(NY:
MRK
)
116.25
+0.22 (+0.19%)
Streaming Delayed Price
Updated: 9:31 AM EDT, Aug 22, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Merck & Co
< Previous
1
2
3
4
5
6
7
8
9
...
71
72
Next >
What's Going On With Merck Stock On Friday?
June 28, 2024
The CDC's Advisory Committee on Immunization Practices recommends Merck's Capvaxive for adults 65+ and certain at-risk individuals 19-64. Merck also announces CHMP's positive recommendation for...
Via
Benzinga
A Closer Look at Merck & Co's Options Market Dynamics
June 27, 2024
Via
Benzinga
Dow Jones Powerhouse Merck Dives On Surprise FDA Rejection
June 27, 2024
The FDA rejected Merck's Daiichi Sankyo-partnered antibody drug conjugate.
Via
Investor's Business Daily
Topics
Stocks
Exposures
Product Safety
US Equities
This Recent FDA Approval Is Bad News for Pfizer
June 27, 2024
One of the pharma giant's top-selling products is about to face some intense competition.
Via
The Motley Fool
Exposures
Product Safety
FDA Declines To Approve Merck-Daiichi Sankyo Partnered Lung Cancer Drug
June 27, 2024
The FDA issued a Complete Response Letter for Daiichi Sankyo and Merck's BLA for patritumab deruxtecan targeting EGFR-mutated NSCLC due to third-party manufacturing facility inspection findings. The...
Via
Benzinga
Exposures
Product Safety
These Are The Best Dow Jones Stocks Of 2024 Thus Far
June 27, 2024
The AI boom helped to produce two best Dow Jones stocks, including newbie Amazon.
Via
Investor's Business Daily
Topics
Artificial Intelligence
Stocks
Exposures
Artificial Intelligence
US Equities
Cracking The Code: Understanding Analyst Reviews For Merck & Co
June 18, 2024
Via
Benzinga
Competitor Analysis: Evaluating Merck & Co And Competitors In Pharmaceuticals Industry
June 18, 2024
Via
Benzinga
Beating Cancer Is Still An Everything-But-Easy Challenge That Pharmaceutical Companies Cannot Solve Overnight
June 26, 2024
On Tuesday, Merck Group revealed an unexpected decision to end a Phase III trial of its cancer drug Xevinapant. This move threatens to undermine confidence the research abilities of the Darmstadt,...
Via
Benzinga
7 Dividend Stocks to Buy Now for Enhanced Returns
June 26, 2024
These dividend stocks can round out a diversified portfolio - or anchor a value-based income investment strategy.
Via
InvestorPlace
Analyst Sees Keros Therapeutics As Next Acceleron, Set For Major Biotech Growth
June 25, 2024
Keros Therapeutics is advancing novel therapies for hematological and cardiopulmonary disorders via TGF-β signaling regulation. Oppenheimer rates KROS Outperform with a $102 price target.
Via
Benzinga
Gossamer Bio's Clean Safety Profile Differentiates It From Merck, Analyst Says
June 25, 2024
Oppenheimer initiated coverage on Gossamer Bio, highlighting seralutinib's clean long-term safety profile for pulmonary arterial hypertension. Seralutinib shows potential in underserved markets.
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
June 25, 2024
Via
Benzinga
Merck & Co Unusual Options Activity For June 14
June 14, 2024
Via
Benzinga
How Is The Market Feeling About Merck & Co?
June 11, 2024
Via
Benzinga
Forget Nvidia: Prominent Billionaires Are Selling It in Favor of These 7 Top-Notch Stocks
June 25, 2024
More than a half-dozen of Wall Street's most-successful billionaire investors dumped shares of Nvidia during the March-ended quarter and made these seven stocks their top buys.
Via
The Motley Fool
3 Undervalued Pharma Stocks to Buy for Dividends and Capital Gains
June 24, 2024
These are the undervalued pharma stocks and represent companies with a deep research pipeline, that provides sustained growth visibility.
Via
InvestorPlace
5 Biotech Stocks With Key Catalysts This Week: Merck, Intellia, Verona, And More
June 24, 2024
Biotech investing is risk-fraught but the returns could be staggering if one chooses to take the educated approach.
Via
Benzinga
AbbVie Inc. Dividend Stock Analysis - Saturday, June 22
June 22, 2024
Here are some highlights from a detailed, quantitative analysis AbbVie Inc. stock. Let's take a closer look at various factors, such as the stock's value and dividend.
Via
Talk Markets
Gilead Sciences Faces Wall Street Speculation About Obesity Drugs Despite Focus On Liver Treatments
June 21, 2024
Gilead Sciences faces Wall Street speculation about its potential in the obesity drug market despite its focus on liver treatments.
Via
Benzinga
3 Top Penny Stocks to Skyrocket Your Wealth in 2024
June 21, 2024
Find out about the top penny stocks to buy this year for a chance to see incredible results down the road as they soar to new heights.
Via
InvestorPlace
Covid-19 Pharma Stars Continue Their Quest To Set New Standards In Cancer Treatment
June 18, 2024
AstraZeneca PLC (NASDAQ: AZN) kicked off the week by receiving approval from the U.S. Food and Drug Administration for its blockbuster cancer drug Imfinzi combined with chemotherapy being used as a...
Via
Benzinga
Exposures
COVID-19
FDA Approves Merck's Pneumococcal Vaccine As First Shot Designed For Adults
June 18, 2024
The FDA has approved Merck's Capvaxive, the first pneumococcal conjugate vaccine for adults, protecting against 21 strains of bacteria. Additionally, Merck's Keytruda received FDA approval for advanced...
Via
Benzinga
Exposures
Product Safety
3 Stocks That Have Soared 179% or More in 2024 and Could Go Even Higher, According to Wall Street
June 17, 2024
These high-flying stocks could have more room to run if analysts are right.
Via
The Motley Fool
3 Crazy Good Stocks to Buy With $500 Right Now
June 12, 2024
For investors with only a little money to spare, these three supercharged stocks represent an outrageous opportunity for future growth.
Via
InvestorPlace
3 Penny Stocks to Buy if You Want to Spend Less and Earn More
June 11, 2024
These penny stocks to buy provide a good opportunity for investors to buy low-priced stocks that provide significant growth potential.
Via
InvestorPlace
3 High-Yield Dividend Stocks to Collect Impressive Payouts Year After Year
June 11, 2024
High-yield dividend stocks can be resilient performers in long-term portfolios and provide steady income and robust growth in June.
Via
InvestorPlace
Healthcare And Biotech Investing: Breakthroughs In The Treatment Of Cancer At ASCO
June 10, 2024
Healthcare stocks underperformed YTD because of weakness in UNH and strength in Technology and Communication Services.
Via
Talk Markets
From $10k to $100k: 3 Stocks With the Potential for Amazing Returns
June 10, 2024
Generate massive returns on investment with these three stocks to buy that have the potential to become market beaters in 2024 and beyond.
Via
InvestorPlace
Nike, Merck, General Motors, And More: CNBC's 'Final Trades'
June 10, 2024
Liz Young of SoFi recommends Energy Select Sector SPDR Fund as her final trade on CNBC's Halftime Report. Jim Lebenthal of Cerity Partners picks General Motors, while Jason Snipe of Odyssey Capital...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
71
72
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.